The presence of hypotheses in the medical literature

American Journal of the Medical Sciences

Volumn 328, Issue 6, 2004, Pages 319-322

  Desbiens, Norman A ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Hypothesis; Randomized controlled trials; Sample size calculations; Scientific methodology

Indexed keywords

CONFIDENCE INTERVAL; CORRELATION ANALYSIS; HYPOTHESIS; MATHEMATICAL COMPUTING; MEDICAL LITERATURE; PRACTICE GUIDELINE; PREVALENCE; REVIEW;

EID: 10644224328     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9629(15)33941-0     Document Type: Article

References (16)

1. Environmental Protection Agency. What is the scientific method? Available at: http://www.epa.gov/maia/html/scientific. html. Accessed October 6, 2004.
2. American Association for the Advancement of Science. The Liberal Art of Science: Agenda for Action. Washington, D.C. 1990, section xiii.
3. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994;272:122-4.
4. Cui L, Hung HM, Wang SJ, et al. Issues related to subgroup analysis in clinical trials. J Biopharm Stat 2002;12:347-58.
5. Gauch HG. Scientific Method in Practice. Cambridge: Cambridge University Press, 2003.
6. Freiman JA, Chalmers TC, Smith H Jr, et al. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 1978;299:690-4.
7. Garfield E. The concept of citation indexing: a unique and innovative tool for navigating the research literature. Available at: http://www.isinet. com/essays/citationindexing/1.html. Accessed September 29, 2004.
8. Harrell FE. Regression Modeling Strategies. 1st ed. New York: Springer-Verlag, 2001.
9. Altman DG, Schulz KF, Moher D, et al. CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134: 663-94.
10. Guidance for Industry. E9 Statistical Principles for Clinical Trials. U.S. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research (CDER). Center for Biologies Evaluation and Research (CBER). September 1998. http://www.fda.gov/cder/ guidance/ICH_E9-fhl.PDF. Accessed September 15, 2004.
11. Begg CB, Cho MK, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996;276:637-9.
12. Instruction for authors. Journal of the American Medical Association. Available at: http://jama.ama-assn.org/ifora_current.dtl#SEC9. Accessed June 22, 2004.
13. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Updated October 2001. Available at: http://www. icmje.org/index.html. Accessed June 22, 2004.
14. Edwardes MD. Sample size requirements for case-control study designs. BMC Medical Research Methodology 2001;1: 11. Available at: http://www. biomedcentral.com/1471-2288/1/ 11. Accessed October 6, 2003.
15. Goodman L. Hypothesis-limited research. Genome Res 1999;9:673-4.
16. Savitz DA. Commentary: prior specification of hypotheses: cause or just a correlate of informative studies? Int J Epidemiol 2001;30:957-8.